Tower Research Capital (TRC)’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-7,678
| Closed | -$11K | – | 6536 |
|
|
2023
Q1 | $11K | Buy |
7,678
+741
| +11% | +$1.06K | ﹤0.01% | 4309 |
|
|
2022
Q4 | $7K | Buy |
6,937
+3,178
| +85% | +$3.21K | ﹤0.01% | 4661 |
|
|
2022
Q3 | $7K | Sell |
3,759
-2,968
| -44% | -$5.53K | ﹤0.01% | 4967 |
|
|
2022
Q2 | $19K | Sell |
6,727
-2,969
| -31% | -$8.39K | ﹤0.01% | 3873 |
|
|
2022
Q1 | $27K | Sell |
9,696
-7,742
| -44% | -$21.6K | ﹤0.01% | 3269 |
|
|
2021
Q4 | $81K | Buy |
17,438
+9,685
| +125% | +$45K | ﹤0.01% | 2379 |
|
|
2021
Q3 | $66K | Buy |
7,753
+5,061
| +188% | +$43.1K | ﹤0.01% | 2742 |
|
|
2021
Q2 | $44K | Buy |
2,692
+425
| +19% | +$6.95K | ﹤0.01% | 3137 |
|
|
2021
Q1 | $50K | Buy |
2,267
+1,347
| +146% | +$29.7K | ﹤0.01% | 3132 |
|
|
2020
Q4 | $28K | Sell |
920
-17,608
| -95% | -$536K | ﹤0.01% | 3638 |
|
|
2020
Q3 | $376K | Buy |
18,528
+16,029
| +641% | +$325K | ﹤0.01% | 1987 |
|
|
2020
Q2 | $38K | Buy |
2,499
+544
| +28% | +$8.27K | ﹤0.01% | 3273 |
|
|
2020
Q1 | $15K | Sell |
1,955
-416
| -18% | -$3.19K | ﹤0.01% | 1858 |
|
|
2019
Q4 | $34K | Buy |
2,371
+2,082
| +720% | +$29.9K | ﹤0.01% | 1588 |
|
|
2019
Q3 | $4K | Sell |
289
-1,086
| -79% | -$15K | ﹤0.01% | 3484 |
|
|
2019
Q2 | $20K | Buy |
1,375
+294
| +27% | +$4.28K | ﹤0.01% | 2192 |
|
|
2019
Q1 | $19K | Buy |
+1,081
| New | +$19K | ﹤0.01% | 2307 |
|